Fosphenytoin Injection, Solution
Product Images NDC 63323-403

7 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fosphenytoin (NDC 63323-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fos05 0004 01

Fos05 0004 01
Chemical structure of Fosphenytoin disodium salt, showing its molecular framework with sodium counterions. This diagram illustrates the arrangement of atoms and bonds specific to Fosphenytoin, an active pharmaceutical ingredient.*
FDA Label Image

Fos05 0004 02

Fos05 0004 02
A line graph showing plasma unbound phenytoin concentration (mcg/mL) over time (hours) after start of infusion up to 2 hours. The graph contains multiple data series represented by different markers (diamonds, squares, triangles). An inset graph charts plasma unbound phenytoin concentration over time up to 96 hours after start of infusion with similar marker differentiation.*
FDA Label Image

Fos05 0004 03

FDA Label Image

Fos05 0004 04

Fos05 0004 04
Label for Fosphenytoin Sodium Injection, USP by Fresenius Kabi USA, LLC showing 100 mg PE per 2 mL (50 mg PE per mL) strength. It is a 2 mL single dose vial labeled for intramuscular or intravenous use. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F).*
FDA Label Image

Fos05 0004 05

Fos05 0004 05
Fosphenytoin Sodium Injection, USP label showing 100 mg phenytoin equivalent (PE) per 2 mL (50 mg PE per mL) in single-dose vials. The label includes dosage information, sterile status, directions for intravenous or intramuscular use, storage instructions at 2° to 8°C, and manufacturer details as Fresenius Kabi USA, LLC. The label also displays the NDC 63323-403-02 and a barcode.*
FDA Label Image

Fos05 0004 06

Fos05 0004 06
Fosphenytoin Sodium Injection, USP label showing 500 mg phenytoin equivalents (PE) per 10 mL (50 mg PE/mL) in a 10 mL single-dose vial. The label indicates sterility, intramuscular or intravenous use, storage requirements (refrigerate at 2° to 8°C), and administration notes. Manufactured by Fresenius Kabi USA, LLC with NDC number 63323-403.*
FDA Label Image

Fos05 0004 07

Fos05 0004 07
Fosphenytoin Sodium Injection, USP 50 mg/mL (500 mg PE per 10 mL) single dose vials for intramuscular or intravenous use. Label shows dosage strength, NDC 63323-403-10, storage instructions to refrigerate at 2 to 8°C, and manufacturer Fresenius Kabi USA, LLC. Packaging contains 10 vials of 10 mL each. Includes details on phenytoin sodium equivalents and injection contents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.